The page you are trying to access is not on our U.S.A. site.

To help you obtain information that is the most relevant to you, would you like to:

Confirm and continue
(Not all products and services might be available to you)

Go to the U.S. website

/siemens/en_GLOBAL/rg_marcom_FBAs/images/diagnostics/branding_images/AACC_2011/IFCC_signal_art_638x144_flip.jpg

Scientific Poster Sessions

Close

Tuesday, July 26, 2011 10:00 a.m. – 12:30 p.m.

Poster No.	Poster Title	Author/Facility	Topic
A-88	Roadmap for harmonization of clinical laboratory measurement procedures	W. G. Miller¹, G. L. Myers², M. L. Gantzer³, S. E. Kahn⁴, E. R. Schönbrunner⁵, L. M. Thienpont⁶, D. M. Bunk⁷, R. H. Christenson⁸, J. H. Eckfeldt⁹, S. F. Lo¹⁰, C. M. Nübling¹¹, C. M. Sturgeon¹². _{¹Virginia Commonwealth University, Richmond, VA, ²American Association for Clinical Chemistry, Washington, DC, ³Siemens Healthcare Diagnostics, Newark, DE, ⁴Loyola University Health System, Maywood, IL, ⁵Life Technologies, Benicia, CA, ⁶Ghent University, Ghent, Belgium, ⁷National Institute of Standards and Technology, Gaithersburg, MD, ⁸University of Maryland, Baltimore, MD, ⁹University of Minnesota, Minneapolis, MN, ¹⁰Medical College of Wisconsin, Milwaukee, WI, ¹¹Paul-Ehrlich Institut, Langen, Germany, ¹²Royal Infirmary of Edinburgh, Edinburgh, United Kingdom}	Factors Affecting Test Results
A-159	Multicenter Performance Evaluation of the RAPIDPoint^® 405 Neonatal Bilirubin Method	S. L. Barnes¹, D. Walck², T. Wilhite², M. Vallen-Thompson³, S. P. Volkir³, D. J. Dietzen⁴, S. Jortani¹. _{¹University of Louisville School of Medicine, Louisville, KY, US; ²St. Louis Children’s Hospital, St. Louis, MO, US; ³Siemens Healthcare Diagnostics Inc., Norwood, MA, US; ⁴Washington University, St. Louis, MO, US}	Pediatric/Fetal Clinical Chemistry

Tuesday, July 26, 2011 2:00 p.m. – 4:30 p.m.

Poster No.	Poster Title	Author/Facility	Topic
B-31	New Emit^® II Plus 6-Acetylmorphine Assay* on the Roche HITACHI 747 and 917 chemistry Analyzers	N. Morjana, J. Hutson, E. Ludlam, G. Siefring _{¹Siemens Healthcare Diagnostics, Inc., Newark, DE, US}	TDM/Toxicology/DAU
B-32	Validation of a Syva^® 6-Acetylmorphine Method on the AU5400 Clinical Chemistry Analyzer	D. Kilgore¹, W. Lynn², D. Michaelsen³. _{¹Siemens Healthcare Diagnostics Inc., Newark, DE, US; ²LabCorp, Research Triangle Park, NC, US; ³PAML, Spokane, WA, US}	TDM/Toxicology/DAU
B-39	An Improved no-manual Extraction Immunoassay for Tacrolimus on the Siemens Dimension^® Clinical Chemistry System	T. Wei, S. Janas, M. Dubowy, F. Celano, Y Zheng, J. Duffy, Y. Yang. _{¹Siemens Healthcare Diagnostics, Inc., Newark, DE, US}	TDM/Toxicology/DAU
B-122	ADVIA Centaur^® Vitamin D Total Assay: Performance Evaluations Assessing Method Comparisions and Expected Values	J. Freeman¹, H. Mindicino¹, A. Bostanian², S. Chapman¹. _{¹Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US; ²Research and Development Institute, Inc., Calabasas, CA, US}	Nutrition/Trace Metals/Vitamins

Wednesday, July 27, 2011 10:00 a.m. – 12:30 p.m.

Poster No.	Poster Title	Author/Title	Topic
C-25	Development of an Immunoassay for BNP* on the Dimension^®EXL™ integrated chemistry system with LOCI^® Module	L. Duggan, A. Amin, J. Duffy, P. Singh, R. Bauer _{¹Siemens Healthcare Diagnostics Inc., Newark, DE, US}	Cardiac Markers
C-46	A Simple, Practical and Profitable Tool for Validation of New Analysers in an Accredited Laboratory	F. Bernabeu Andreu¹, C. Caballero-Garcia¹, A. Esteban-Susaeta¹, T. Brotons-Rodriguez¹, L. Maceda-Garcia¹, A. Rodriguez-Martin¹, L. Sivera- Monzo¹, M. Manero-Merino², C. Coca-Martin¹, I. Arribas¹. _{¹Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain, ²Siemens Healthcare Diagnostics, S. L., Madrid, Spain}	Automation/Computer Applications
C-50	Analysers In An Accredited Laboratory	P. Datta, J. Dai. _{¹Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US}	Automation/Computer Applications
C-51	A New, High-Throughput Assay for Ferritin, Evaluated on the ADVIA^® Chemistry Systems	P. Datta, J. Dai. _{¹Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US}	Automation/Computer Applications
C-66	Analytical and Clinical Performance of the Enhanced Liver Fibrosis (ELF™) Test in the ADVIA Centaur^® Immunoassay Systems from Siemens	P. W. Dillon¹, J. Cheek¹, H. Leipold¹, R. Cross², A. Yarovoy¹, J. Wong¹. _{¹Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US; ²iQur, Ltd., London, UK}	Clinical Studies/Outcomes

Wednesday, July 27, 2011 2:00 p.m. – 4:30 p.m.

Poster No.	Poster Title	Author/Facility	Topic
D-05	Automatic Urine Strip Identification and Strip Quality Check on the CLINITEK Advantus^® Analyzer	A. E. Zercher, L. S. Schulman, C. T. Zimmerle. _{¹Siemens Healthcare Diagnostics Inc., Elkhart, IN, US}	Point-of-Care Testing
D-87	Performance Evaluation of a Prototype CHIV Assay Method on the ADVIA Centaur^® System	S. Patibandla¹, S. Shin¹, R. Martin¹, H. Yu¹, S. Chowdhury¹, K. Katlowitz², M. Narlieva², A. Fox², J. Freeman¹, L. Baker¹. _{¹Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US; ²Montefiore Medical Center, Bronx, NY, US}	Infectious Disease
D-90	Syphilis Testing: An Automated Immonoassay Method-Comparison Study	J. S. Shieh¹, M. Stanley¹, T. Bal², U. Nabeck³. _{¹TPMG Kaiser Regional Lab, Berkeley, CA, US; ²Siemens Healthcare Diagnostics, Inc., Los Angeles, CA, US; ³Siemens Healthcare Diagnostics Products HmbH, Marburg, Germany}	Infectious Disease
D-98	A Multicenter Evaluation of the Performance of the ADVIA Centaur^® Anti-HBs2 Assay on the ADVIA Centaur Immunoassay System	C. Saxton¹, W. Lee², J. Balko², E. Schiff³, M. deMedina³, G. Randive¹, S. Chapman-Montgomery¹, M. Anostario¹, R. Levine¹. _{¹Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US; ²University of Texas Southwestern, Dallas, TX, US; ³University of Miami Center for Liver Diseases, Miami, FL, US}	Infectious Disease
D-108	Performance Evaluation of a Prototype CMVG Assay on the ADVIA Centaur^® System	B. Belth, Y. Li, J. Hansen, S. Patibandla, L. Baker. _{¹Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US}	Infectious Disease
D-127	A Multicenter Evaluation of the Analytical Performance of the ADVIA Centaur^® EHIV Assay on the ADVIA Centaur CP Immunoassay System	J. Patel1, E. Schiff², M. D. de Medina², G. Randive¹, S. Chapman-Montgomery¹, E. Saxton¹, P. Dillon¹. _{¹Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US; ²University of Miami Center for Liver Diseases, Miami, FL, US}	Infectious Disease

Thursday, July 28, 2011 9:30 a.m. – 12:00 p.m.

Poster No.	Poster Title	Author/Facility	Topic
E-19	Performance Evaluation of a New IMMULITE® Erythropoietin Assay	W. L. Roberts¹, G. M. Lambert-Messerlian², C. Delaney³, B. Plouffe⁴, R. Ludewig⁴, A. Woods⁴, J. D. Lei⁴, S. Thompson⁴. _{¹Department of Pathology, University of Utah, Salt Lake City, UT, US; ²Women and Infants Hospital of Rhode Island, Providence, RI, US; ³Quest Diagnostics, Valencia, CA, US; ⁴Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US}	Endocrinology/Hormones
E-30	Development of the ADVIA Centaur® Systems Enhanced Testosterone (TSTO2) Assay	K. E. Mickelson, K. Thakur, S. Lin, K. Yokoyama. _{¹Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US}	Endocrinology/Hormones
E-36	Evaluation of the Vitamin D Total Immunoassay on the ADVIA Centaur® System	H. Mindicino¹, S. Chapman-Montgomery¹, N. Sahakian², A. Woods³, T. Thorne¹, J. Fernandez¹, J. Freeman¹._{¹Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US; ²Siemens Healthcare Diagnostics Inc., Los Angeles, CA, US; ³Siemens Healthcare Diagnostics Inc., Berkeley, CA, US}	Endocrinology/Hormones
E-41	Performance Evaluation of the Dimension Vista® LOCI® Estradiol (E2) Assay	R. M. Ruiz¹, S. Pottorf², J. Melchior³, R. H. Christenson¹._{¹University of Maryland School of Medicine, Baltimore, MD, ²Methodist Medical Center of Illinois, Peoria, IL, ³Siemens Healthcare Diagnostics Inc., Newark, DE}	Endocrinology/Hormones
E-53	Functional Sensitivity of Seven Commercial Thyroid Stimulating Hormone Immunoassays	W. E. Owen¹, M. Gantzer², J. M. Lyons², W. L. Roberts³. _{¹ARUP Institute for Clinical and Experimental Pathology®, Salt Lake City, UT, ²Siemens Healthcare Diagnostics, Newark, DE, ³Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT}	Endocrinology/Hormones
E-83	D-Dimer Stability and Matrix Study in Whole Blood and Plasma on the ADVIA Centaur® Immunoassay System	F. S. Apple¹, M. M. Murakami¹, J. M. Kaczmarek¹, H. Mindicino², W. Canfield², D. D. Castellone². _{¹Hennepin County Medical Center, Minneapolis, MN, US; ²Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US}	Hematology/Coagulation
E-89	D-Dimer Method Comparison across Four Platforms: ADVIA Centaur®, IMMULITE® 2000, IMMULITE® 2500 and VIDAS	R. Christenson¹, J. Gray¹, H. Mindicino², L. Kish², D. D. Castellone². _{¹University of Maryland Medical School, Baltimore, MD, US; ²Siemens Healthcare Diagnostics Inc., Tarrytown, NY, US}	Hematology/Coagulation
E-125	New free light chain assays based on monolonal antibodies, a Performance Evaluation report	W. K. Gentzer¹, B. Pepperkok², R. Hoedemakers³, H. te Velthuis⁴._{¹Siemens Healthcare Diagnostics, Marburg, Germany, ²Labor Limbach und Kollegen, Medizinisches Versorgungszentrum, Heidelberg, Germany, ³Jeroen Bosch Hospital, Laboratory of Clinical Chemistry and Hematology, Den Bosch, Netherlands, ⁴Sanquin Reagents, Business Unit Reagents, Amsterdam, Netherlands}	Immunology

^{*Under development. Not available for sale in the U.S.}

Stay up-to-date with the latest news from Siemens Healthcare Diagnostics and sign-up for our eNewsletter.

Did this information help you?

Print this page